THESEUS PHARMACEUTICALS, INC. Retained Earnings
THESEUS PHARMACEUTICALS, INC. had Retained Earnings of -$155.08 million as of 2023-09-30, per its 10-Q filed 2023-11-17.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2023-11-17
- 2023-09-30: Retained Earnings (Accumulated Deficit) -$155.08M.
- 2023-06-30: Retained Earnings (Accumulated Deficit) -$141.58M.
- 2023-03-31: Retained Earnings (Accumulated Deficit) -$126.77M.
- 2022-12-31: Retained Earnings (Accumulated Deficit) -$112.19M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2023-09-30 | -$155.08M 10-Q · filed 2023-11-17 |
| 2023-06-30 | -$141.58M 10-Q · filed 2023-08-10 |
| 2023-03-31 | -$126.77M 10-Q · filed 2023-05-11 |
| 2022-12-31 | -$112.19M 10-Q · filed 2023-11-17 |
| 2022-09-30 | -$98.47M 10-Q · filed 2022-11-03 |
| 2022-06-30 | -$83.72M 10-Q · filed 2022-08-11 |
| 2022-03-31 | -$72.08M 10-Q · filed 2022-05-12 |
| 2021-12-31 | -$61.58M 10-K · filed 2023-03-09 |
| 2021-09-30 | -$52.92M 10-Q · filed 2021-11-15 |
| 2020-12-31 | -$34.27M 10-K · filed 2022-03-10 |